Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 1;5(6):132-135.
doi: 10.1002/cld.483.

Personalized management of hepatocellular carcinoma based on molecular information: future prospects

Nicolas Goossens  1 , Yujin Hoshida  2
Affiliations

Personalized management of hepatocellular carcinoma based on molecular information: future prospects

Nicolas Goossens et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Impact of HCV eradication on HCC incidence. HCC incidences in all HCV‐infected patients and patients with advanced fibrosis were obtained from Morgan et al,10 Aleman et al,11 and van der Meer.12 Abbreviations: HCV, hepatitis C virus; HCC, hepatocellular carcinoma; SVR, sustained virological response. Some images were obtained from Servier Medical Art (www.servier.com).
Figure 2
Figure 2
Molecular classification of HCC tumor. Abbreviations: AFP, alpha‐fetoprotein; TGF‐β, transforming growth factor β.
Figure 3
Figure 3
HCC risk predictor‐based personalized/stratified patient management. Abbreviations: CU‐HCC, Chinese University‐HCC score; GAG‐HCC: Guide with Age, Gender, HBV DNA, Core promoter mutations and Cirrhosis, HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; LSM, liver stiffness measurement; REACH‐B, Risk estimation for hepatocellular carcinoma in chronic hepatitis B; REVEAL‐B/REVEAL‐HCV, Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV/HCV. Some images were obtained from Servier Medical Art (www.servier.com).
See this image and copyright information in PMC

References

    1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29. - PubMed
    1. El‐Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? Hepatology 2014;60:1767–1775. - PMC - PubMed
    1. Michelotti GA, Machado MV, Diehl AM. NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol 2013;10:656–665. - PubMed
    1. Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology 2014;59:2188–2195. - PubMed
    1. Oda K, Uto H, Mawatari S, Ido A. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies. Clin J Gastroenterol 2015;8:1–9. - PubMed

LinkOut - more resources